Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000298466 | SCV001651787 | likely benign | Alpha-1-antitrypsin deficiency | 2024-12-16 | criteria provided, single submitter | clinical testing | |
| Eurofins Ntd Llc |
RCV000734670 | SCV000862827 | uncertain significance | not provided | 2018-08-08 | criteria provided, single submitter | clinical testing | |
| Illumina Laboratory Services, |
RCV000298466 | SCV000389658 | uncertain significance | Alpha-1-antitrypsin deficiency | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Prevention |
RCV004748725 | SCV005367089 | uncertain significance | SERPINA1-related disorder | 2024-04-08 | no assertion criteria provided | clinical testing | The SERPINA1 c.211A>C variant is predicted to result in the amino acid substitution p.Ser71Arg. This variant was reported as likely benign in an individual with Cholestasis and HCV Cirrhosis (Renoux et al. 2018. PubMed ID: 30223862). This variant is reported in 0.059% of alleles in individuals of Latino descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |